Category: Nanoreviv

NanoReviv was founded in 2023 by Amokrane REGHAL, MD microbiologist cumulating over 20 years experience in antibiotics (Pasteur Institute, Bayer etc.). Our specialty is reformulating existing molecules to give them a second life. We are currently developing Staph-Ex, a product based on the concept that drug-resistant bacterial infections could be effectively treated by targeted administration of a drug formulation in lipid nanocapsules, combining immediate and controlled release.